Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Koller

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Fortschritte Der Neurologie-Psychiatrie|January 4, 2023
[Psychedelics in Psychiatry - Development and Current State in Germany]Uwe Herwig, Lea Mertens, Sergio Pérez Rosal, et al.
Addiction Biology|August 5, 2009
No association of alcohol dependence with SLC6A5 and SLC6A9 glycine transporter polymorphismsGabriele Koller, Peter Zill, Christoph Fehr, et al.
Frontiers in Psychiatry|March 6, 2026
Outpatient psychotherapeutic treatment of gambling disorder - lessons learned from BavariaBianca Pitzschel, Rebekka Redel, Martin Tauscher, et al.
The American Journal of Drug and Alcohol Abuse|August 20, 2011
A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot studyMichael Soyka, Claudia Limmer, Robert Lehnert, et al.
Drug and Alcohol Dependence Reports|June 8, 2026
Service utilization patterns in cocaine use disorder: A data-driven studyCarlotta Riemerschmid, Larissa Schwarzkopf, Gabriele Koller, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trialMichael Soyka, Gabriele Koller, Peggy Schmidt, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 5, 2015
Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related AggressionUlrich W Preuss, Gabriele Koller, Agnieszka Samochowiec, et al.
Journal of Cannabis Research|April 29, 2026
Through the haze: a multinational cross-sectional comparison of cannabis risk knowledge gaps among young adultsAnne Maiwald, Elena Gomes de Matos, Sally Olderbak, et al.
Journal of Clinical Psychopharmacology|November 18, 2008
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trialMichael Soyka, Martin Lieb, Sabine Kagerer, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2020
Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatmentFlorian J Raabe, Elias Wagner, Judith Weiser, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Fortschritte Der Neurologie-Psychiatrie|January 4, 2023
[Psychedelics in Psychiatry - Development and Current State in Germany]Uwe Herwig, Lea Mertens, Sergio Pérez Rosal, et al.
Addiction Biology|August 5, 2009
No association of alcohol dependence with SLC6A5 and SLC6A9 glycine transporter polymorphismsGabriele Koller, Peter Zill, Christoph Fehr, et al.
Frontiers in Psychiatry|March 6, 2026
Outpatient psychotherapeutic treatment of gambling disorder - lessons learned from BavariaBianca Pitzschel, Rebekka Redel, Martin Tauscher, et al.
The American Journal of Drug and Alcohol Abuse|August 20, 2011
A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot studyMichael Soyka, Claudia Limmer, Robert Lehnert, et al.
Drug and Alcohol Dependence Reports|June 8, 2026
Service utilization patterns in cocaine use disorder: A data-driven studyCarlotta Riemerschmid, Larissa Schwarzkopf, Gabriele Koller, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trialMichael Soyka, Gabriele Koller, Peggy Schmidt, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 5, 2015
Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related AggressionUlrich W Preuss, Gabriele Koller, Agnieszka Samochowiec, et al.
Journal of Cannabis Research|April 29, 2026
Through the haze: a multinational cross-sectional comparison of cannabis risk knowledge gaps among young adultsAnne Maiwald, Elena Gomes de Matos, Sally Olderbak, et al.
Journal of Clinical Psychopharmacology|November 18, 2008
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trialMichael Soyka, Martin Lieb, Sabine Kagerer, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2020
Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatmentFlorian J Raabe, Elias Wagner, Judith Weiser, et al.
Pageof 6